News & events
| News
AusVaxSafety commences routine surveillance of 2024 seasonal influenza vaccines
| News
Vaccine safety in Australia AusVaxSafety summary report now available
| News
What to expect in the days after your XBB.1.5 COVID-19 vaccine
| News
Shingrix® vaccine safety data now available
| News
AusVaxSafety monitoring monovalent Omicron XBB.1.5 variant COVID-19 vaccine safety
| News
AusVaxSafety commences enhanced surveillance of Shingrix® following addition to the NIP schedule
| News
AusVaxSafety surveillance of 2023 seasonal flu vaccines concludes with no safety issues identified
| News
Vaxtracker wins Hunter New England Health Excellence Award
| News
Subcutaneous and intradermal administration of mpox vaccine well tolerated, AusVaxSafety study finds
| News
New bivalent BA.4/BA.5 COVID-19 booster vaccines well tolerated by Australians, new AusVaxSafety data show
All news & events
| News

AusVaxSafety report a Clear Communication Awards finalist

We are very pleased to announce that the AusVaxSafety report, Vaccine safety in Australia 2016–17, has been selected as a finalist in two categories for the Clear Communication Awards. 
The Clear Communication Awards are the first and only awards in Australia to recognise and promote excellence in clear communication. The awards acknowledge digital and print examples of work that combine excellence in design, communication principles and plain language to make it as easy as possible for the user to find the information they need.
The Vaccine safety in Australia report shows how parents and carers responded to the SMS about their child's health a few days after their vaccination at each schedule point in the National Immunisation Program in 2016–17. The report was designed by Biotext in collaboration with NCIRS, and included data from SmartVax.